On the other hand, high rates of TERT promoter mutations were identified in some tumour types including glioblastoma, bladder cancer, cutaneous melanoma, hepatocellular carcinoma and squamous cell carcinoma (SCC) of the skin and oral mucosa (Huang et al., 2015a). This evidence concerns the gene TERT and urinary bladder cancer.